Global Digital Pathology
Market Report
2024
Digital Pathology Market Report 2024 (Global Edition)
Delivery Includes:- Market Timeline 2019 till 2031, Market Size, Revenue/Volume Share, Forecast and CAGR, Competitor Analysis, Regional Analysis, Country Analysis, Segment Analysis, Market Trends, Drivers, Opportunities, Restraints, ESG Analysis, Porters Analysis, PESTEL Analysis, Market Attractiveness, Patent Analysis, Technological Trend, SWOT Analysis, COVID-19 Analysis, Consumer Behavior Analysis, etc.
The base year for the calculation is 2023 and 2019 to 2023 will be historical period. The year 2024 will be estimated one while the forecasted data will be from year 2025 to 2031. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
| Share your contact details to receive free updated sample copy/pages of the recently published edition of Digital Pathology Market Report 2024.
Global Digital Pathology Market Report 2024 Market Size Split by Type (Human, Veterinary), by End-use (Pharma & Biotech, Academia, Hospitals), by Product (Scanner, Software, Storage System)
According to cognitive market research-"Global Digital Pathology market size 2023 was XX Million. The Digital Pathology Industry compound annual growth rate (CAGR) will be XX% from 2024 till 2031."
- The device segment held the greatest share (XX) in 2023 and is expected to increase at a profitable pace over the forecast period.
- In 2023, the hospital segment dominated the market, accounting for XX%.
- In 2023, the human pathology segment will account for around XX% of the worldwide digital pathology market, driven by the implementation of digital technology to improve illness diagnosis and laboratory productivity
- North America has the biggest market share in terms of sales due to ongoing R&D investments, government support for technologically advanced systems, increasing digital imaging use, and the presence of major players
- Asia-Pacific is predicted to develop the fastest throughout the projection period, driven by rising digital imaging penetration in emerging nations, rising healthcare spending, medical innovation, and demand for low-cost digital pathology services
| Base Year | 2023 |
| Historical Data Time Period | 2019-2023 |
| Forecast Period | 2024-2031 |
| Global Digital Pathology Market Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 9.11% |
| Market Split by Type |
|
| Market Split by End-use |
|
| Market Split by Product |
|
| List of Competitors |
|
| Regional Analysis |
|
Country Analysis |
|
Key Qualitative Information Covered |
|
Report scope is customizable as we have a huge database of Digital Pathology industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Digital Pathology Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Digital Pathology Market Report Description
Introduction of the digital pathology market
Digital pathology is the process of converting glass slides into digital slides that may be viewed, handled, and understood using a computer display. It is a dynamic image-based system that enables the acquisition, management, and analysis of pathology data from digitised glass slides. Its uses in healthcare include primary diagnosis, diagnostic consultation, and clinical research. High-throughput scanning, quantitative analysis, and safe data archiving are some examples of life science applications. Digital pathology is rapidly gaining traction as a critical technology for teaching, tissue-based research, medication development, and human pathology globally. Its goal is to minimise laboratory costs, increase operational efficiency, boost productivity, and improve treatment decisions and patient care.
It is expected that the rising prevalence of chronic illnesses will increase the medical urgency to adopt digital pathology to improve existing patient diagnostic imaging measures while lowering the high cost of conventional diagnosis. Furthermore, the expanding senior population, which is more prone to chronic ailments, is expected to drive up demand for technologically advanced diagnostic methods. The growing use of digital pathology in education and training, as well as the incorporation of AI into digital pathology systems, are important drivers of market growth.
Current dynamics of the digital pathalogy market
Key drivers of the Digital Pathology market
- Technological advancements fueling the expansion of the market
Growth in the market is being driven by the digitalization of pathology workflow, rivalry among major competitors, and the requirement for high-throughput algorithms in drug discovery. In March 2022, Nucleai, a company that creates pathology platforms driven by Al, successfully closed a USD 33 million Series B fundraising round. It is anticipated that this funding would help the platform grow and increase its visibility among contract research organisations and biopharma businesses.
https://nucleai.ai/nucleai-series-b-financing/
The market is anticipated to increase as a result of increasing expenditures made by domestic businesses and industry players to provide new products and technologies in response to the expanding need for digital diagnostic tools. The industry is also being driven by the rapid technology improvements in digital pathology systems, including numerous fibre optic links, computerization, robotic light microscopy, and digital imaging. The industry is also being driven by the rapid technology improvements in digital pathology systems, including numerous fibre optic links, computerization, robotic light microscopy, and digital imaging. When compared to conventional light microscopes, whole slide imaging has benefits that open profitable prospect.
Microarray technology and the release of predictive models such as hybrid models and API algorithms are anticipated to propel the growth of the digital image analysis market. An increasing number of people are choosing computer-aided diagnosis, which integrates image processing, physics, mathematics, and computational algorithms to enable effective illness detection, assessment of disease development, and identification of anatomical structures.
Constraints for the global Digital Pathology market
- Expensive Initial Expenses for Device Installation to Restrain Market Expansion
Even yet, there are advantages and uses for these systems in pathology in contemporary medicine. The process of digitising equipment requires a significant initial investment for system installation and training in order to maintain workflow regularity. Digital equipment may be costly, and in order to analyse, exchange, and retain data, software is needed. This software can be purchased separately or as part of a whole system package.
For example, an NCBI article from 2022 states that the digital pathology scanners range in price from $100,000 to $400,000. In addition to the indicated price, the cost of staff and pathologist training, technical support, and digital slide storage is included in the integration of digital solutions in pathology.
https://www.researchgate.net/publication/341958470_Digital_pathology_as_a_platform_for_primary_diagnosis_and_augmentation_via_deep_learning
Furthermore, because high-throughput scanners are so expensive, small and even mid-sized pathology laboratories find it difficult to purchase whole slide images (WSI). As of 2020, the average cost of a piece of WSI was around USD 237,000 globally.Compared to the number of pathologists entering the industry, more pathologists have been retiring in recent years. The severe lack of pathologists has had a direct impact on the industry. Because these pathology tools are expensive and need installation, fewer customers are adopting and training for these systems, which has a negative impact on the market.
Opportunities for the global Digital Pathology market
- Artificial Intelligence Integration Will Revolutionise the Market
One significant trend in the worldwide market is the rising use of AI-based digital solutions by major users, which is a result of a greater need for workflow management. Major technological patenting businesses are becoming more and more focused on providing a tailored platform for important stakeholders, which gives them a competitive edge in the market. Key players in the machine learning and Al solutions development space should also be able to meet the growing need for advanced pathology solutions, which will drive market expansion.
For example, F. Hoffman-La Roche Ltd. introduced three AI-based digital pathology algorithms for deep learning picture analysis in December 2021. The algorithms were created for Research Use Only (RUO) to assist pathologists in assessing breast cancer markers, Ki-67, ER, and PR.
In addition, a number of businesses are concentrating on obtaining regulatory clearances for medical devices that incorporate Al in order to introduce goods onto the market and improve pathological operations.
For example, the Medtech business Sigtuple obtained permission from the U.S. FDA in September 2023 for its blood smear application. Digital microscopy with Al assistance uses this apparatus.Furthermore, it is projected that deliberate efforts to create and standardise sharing platforms would facilitate the smooth exchange of data throughout the sector, hence fostering the use of AI in pathology and, in turn, the market's expansion.
Impact of COVID-19 on the global Digital Pathology market
During the COVID-19 pandemic, governments, research institutes, and pharmaceutical and biotech companies prioritised quick technology for precise diagnosis and vaccine development. This impacted diagnostic services, notably histopathology departments, which were already underfunded and overcrowded. During the pandemic, digital pathology was critical in ensuring the continuity of clinical services and pathology research.
The digitization of pathological systems, the proliferation of digital devices, and favourable emergency use case rules have all contributed to market growth. To restrict the virus's transmission, governments implemented lockdowns and social distancing measures, resulting in a dramatic decline in in-person patient consultations. In April 2020, the US FDA established a regulation for digital pathology equipment that expanded their availability for remote examination and reporting of scanned digital pictures of pathology slides.
https://downloads.regulations.gov/FDA-2020-D-1138-0078/attachment_1.pdf
However, patient volume increased in 2021 due to increased immunisation coverage in the general population. The market is predicted to grow rapidly in 2022, with a substantial CAGR throughout the forecast period, owing to widespread acceptance of these products and services.
During the pandemic, digital pathology was critical in ensuring the continuity of clinical services and pathology research. In September 2021, there was a considerable increase in the number of pathologists working from home, as well as an increase in primary diagnoses and consultations conducted using digital pathology. Investment in laboratory expansion and market penetration by key manufacturers are expected to drive market growth. Telehealth consultations are likely to drive market development, with the Department of Health and Human Services reporting over 28 million visits during the epidemic. Thus the effect of covid-19 pandemic on the digital pathology market was fairly positive.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035352/
We have various report editions of Digital Pathology Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Competitive Landscape
Major market companies are investing heavily in research and development to expand their product lines, which will help the digital pathology market grow even more. Market participants are also pursuing a variety of strategic measures to expand their global footprint, including new product releases, contractual agreements, mergers and acquisitions, increased investment, and collaboration with other organisations. To expand and compete in an increasingly competitive and rising market, digital pathology competitors must offer cost-effective products.One of the key business tactics used by manufacturers in the global digital pathology industry to help clients and develop the market sector is to produce locally to lower operational costs. In recent years, the digital pathology sector has offered medicine.
• In April 2022, 3DHISTECH Ltd. inked an agreement with the Catalan Health Institute (ICS) to adopt digital pathology tools throughout a network of 8 institutions, 168 pathologists, and over 1 million slides per year as part of the DigiPatICS effort. With a primary focus on creating market presence, the development strengthens the company's position as a leading brand in the industry.
• In March 2022, the CE-IVD-marked Ion Torrent Genexus Dx Integrated Sequencer was introduced. This automated next-generation sequencing (NGS) equipment can be used in clinical laboratories for diagnostic and research purposes. It was released by Thermo Fisher Scientific, Inc.
Top Companies Market Share in Digital Pathology Industry: (In no particular order of Rank)
- Danaher Corporation
- Digipath
- Glencoe Software
- Hamamatsu Photonics
- Indica Labs
- Koninklijke Philips
- Nikon Corporation
- PerkinElmer
- Pixcelldata
- Visiopharm
- Leica Biosystems
- Ventana Medical Systems
- 3DHISTECH
- HCL Technologies
- Pathology Devices
- Biogeniux
- OptraSCAN
- Pathcore
- Sectrae
- Confidential Data
- Access The Paid Version
- Data Hidden
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
Which Region will dominate the Market in 2024, and Which Region is Expanding at the Fastest CAGR?
North America has the biggest market share in terms of sales due to ongoing R&D investments, government support for technologically advanced systems, increasing digital imaging use, and the presence of major players. In North America, the United States holds the market lead. This growth is due to enterprises focused on digital pathology research and building better technologies to improve image analysis in the country. The increased use of digital pathology for disease diagnosis, combined with favorable reimbursement rules in the United States, which improve the standard of cancer diagnosis, is expected to drive regional expansion. The growing use of digital pathology in education and training, as well as the incorporation of AI into digital pathology systems, are key drivers of regional market growth.
Asia-Pacific is predicted to develop the fastest throughout the projection period, driven by rising digital imaging penetration in emerging nations, rising healthcare spending, medical innovation, and demand for low-cost digital pathology services. The Asia-Pacific healthcare business has been severely impacted by the rising cancer incidence rates. Growing need for innovative treatment alternatives, improved patient care facilities, and lower laboratory costs are all likely to drive demand upward. Japan has the greatest market share, accounting for more than 25% of the total Asia-Pacific digital pathology market. Furthermore, the country is predicted to maintain its leading position during the projected time. However, the Indian market for digital pathology is expected to have the highest CAGR.
The current report Scope analyzes Digital Pathology Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
- North America (United States, Canada, Mexico)
- Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
- Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
- South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
- Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)
Digital Pathology Market Share (%) by Region (2019-2031)
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
Digital Pathology Market Analysis
Global Digital Pathology Market Report 2024 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Digital Pathology Industry growth. Digital Pathology market has been segmented with the help of its Type, End-use Product , and others. Digital Pathology market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
Which type segment dominated the market in 2023?
In 2023, the human pathology segment will account for around XX% of the worldwide digital pathology market, driven by the implementation of digital technology to improve illness diagnosis and laboratory productivity. The rising frequency of chronic diseases among people has increased demand for digital pathology. The segment is estimated to dominate the global market in 2023, owing to increased cancer research activities and cooperation between academic institutions and pathology laboratories.
Digital Pathology Market Share (%) by Type in 2019-2031
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Digital Pathology Industry. Request a Free Sample PDF!
Which end-use segment dominated the market in 2023?
In 2023, the hospital segment dominated the market, accounting for XX%. Hospitals are the preferred healthcare setting for disease diagnosis and treatment. Developments in hospital laboratories are critical to meeting patients' changing requirements, as more hospitals strive to provide a wide range of services within their facilities. A lot of hospitals are using digital scanning techniques to increase patient compliance and speed up diagnoses. For example, in March 2023, Ibex (Ibex Medical Analytics) was awarded a Path LAKE contract to provide AI-enabled solutions to 25 NHS to aid cancer diagnosis.
https://ibex-ai.com/pathlake-contracts/#:~:text=Tel%20Aviv%2C%20Israel%20%E2%80%93%20March%207,diagnosis%20at%2025%20NHS%20Trusts.
Digital Pathology Market Share (%) by End-use in 2019-2031
2019
2023
2031
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Digital Pathology Product Segment Analysis
Which product segment held the greatest market share in 2023?
The product segment held the greatest share (XX) in 2023 and is expected to increase at a profitable pace over the forecast period. The device section includes slide management systems and scanners. The segment's growth is driven to the increased use of digital pathology in academic research activities with higher resolution. For example, in June 2022, F. Hoffmann-La Roche Ltd. got CE certification for its VENTANA DP 600 slide scanner, a next-generation, high-capacity slide scanner that produces high-resolution digital images of stained tissue samples to aid in cancer diagnosis and treatment planning.
https://diagnostics.roche.com/global/en/news-listing/2022/roche-launches-ventana-dp600-slide-scanner-for-digital-pathology-enhancing-patient-care-with-precision-diagnostics.html
The device segment is further divided into scanners, tissue microarrays, and others. Global need for digital databases to store specimens is expected to drive segment expansion during the forecast period. The scanner segment is predicted to grow at the quickest rate during the forecast period because to increased partnerships between industry participants for launches and distribution.
- Scanner
- Software
- Storage System
Author's Detail
Anushka GoreResearch Associate at Cognitive Market Research
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the medical devices & consumables industry. She has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services. Her expertise in Market Research and business intelligence has equipped her with the skills necessary to analyze complex information and provide strategic recommendations.
In her current role, Anushka is a highly motivated and detail-oriented research analyst with a passion for uncovering valuable insights from data. She thrives in dynamic environments where her analytical abilities and research expertise can contribute to informed decision-making for businesses. Her collaborative approach facilitated effective communication of insights, fostering a data-driven culture within the organization.Anushka remains an invaluable asset in the dynamic landscape of market research.
Author's Conclusion
The need for pathologists is decreasing, telepathology and AI-powered diagnostics are becoming more and more popular, and growing cancer rates are all contributing to the market's projected rise. The human pathology segment is anticipated to lead the market because to an increase in cancer research efforts. With its potential to enhance patient outcomes, expedite diagnosis, and streamline workflows, the digital pathology industry offers a bright future.
Frequently Asked Questions
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Latest News about Digital Pathology Market
Sources from Medical Devices & Consumables Industry
- http://www.trade.gov
- http://www.gov.uk
- http://www.fda.gov
- http://www.hhs.gov
- http://www.who.int
- http://www.bls.gov
- http://www.gao.gov
- http://www.ncbi.nlm.nih.gov
- http://www.healthcaredive.com
- http://www.weforum.org
- http://www.health.gov.za
- http://www.usaid.gov
- http://www.eumdr.com
- http://www.cdc.gov
- http://www.ama-assn.org
- http://www.washingtonpost.com
- http://www.ecfr.gov
- http://www.hbr.org
- http://www.worldbank.org
- http://www.commission.europa.eu
- http://www.cbi.eu
- http://www.unicef.org
- http://www.ecipe.org
- http://www.ema.europa.eu
Digital Pathology Market Report Table of Content
Disclaimer:
- This is just a redacted sample pages of the actual deliverable report and only for representative purposes
- Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
- The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
- Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
- If applicable; On Request Volume Data will also be provided (at an Additional Cost).
| Type | Human, Veterinary |
| End-use | Pharma & Biotech, Academia, Hospitals |
| Product | Scanner, Software, Storage System |
| List of Competitors | Danaher Corporation, Digipath, Glencoe Software, Hamamatsu Photonics, Indica Labs, Koninklijke Philips, Nikon Corporation, PerkinElmer, Pixcelldata, Visiopharm, Leica Biosystems, Ventana Medical Systems, 3DHISTECH, HCL Technologies, Pathology Devices, Biogeniux, OptraSCAN, Pathcore, Sectrae |
This chapter will help you gain GLOBAL Market Analysis of Digital Pathology. Further deep in this chapter, you will be able to review Global Digital Pathology Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
-
1.1 Global Digital Pathology Market Size, Trend Analysis 2019 - 2031
-
1.2 Global Digital Pathology Market Size By Regions 2019 - 2031
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
-
1.2.1 Global Digital Pathology Revenue Market Size By Region
-
-
1.3 Global Digital Pathology Market Size By Type 2019 -2031
-
1.3.1 Human Market Size
-
1.3.2 Veterinary Market Size
-
-
1.4 Global Digital Pathology Market Size By End-use 2019 -2031
-
1.4.1 Pharma & Biotech Market Size
-
1.4.2 Academia Market Size
-
1.4.3 Hospitals Market Size
-
-
1.5 Global Digital Pathology Market Size By Product 2019 -2031
-
1.5.1 Scanner Market Size
-
1.5.2 Software Market Size
-
1.5.3 Storage System Market Size
-
-
1.6 Global Level Competitor Analysis (Subject to Data Availability (Private Players))
-
1.7 Executive Summary Global Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
-
1.7.1 Regional Market Revenue Summary 2019 vs 2024 vs 2031
-
1.7.2 Global Market Revenue Split By Type
-
1.7.3 Global Market Revenue Split By End-use
-
1.7.4 Global Market Revenue Split By Product
-
1.7.5 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
-
Chapter 2 North America Market Analysis
-
2.1 North America Digital Pathology Market Size 2019 - 2031
-
2.1.1 North America Digital Pathology Market Size By Country 2019 - 2031
-
2.1.2 North America Digital Pathology Market Size by Type 2019 -2031
-
2.1.2.1 North America Human Market Size
-
2.1.2.2 North America Veterinary Market Size
-
-
2.1.3 North America Digital Pathology Market Size by End-use 2019 -2031
-
2.1.3.1 North America Pharma & Biotech Market Size
-
2.1.3.2 North America Academia Market Size
-
2.1.3.3 North America Hospitals Market Size
-
-
2.1.4 North America Digital Pathology Market Size by Product 2019 -2031
-
2.1.4.1 North America Scanner Market Size
-
2.1.4.2 North America Software Market Size
-
2.1.4.3 North America Storage System Market Size
-
-
Chapter 3 Europe Market Analysis
-
3.1 Europe Digital Pathology Market Size 2019 - 2031
-
3.1.1 Europe Digital Pathology Market Size By Country 2019 - 2031
-
3.1.2 Europe Digital Pathology Market Size by Type 2019 -2031
-
3.1.2.1 Europe Human Market Size
-
3.1.2.2 Europe Veterinary Market Size
-
-
3.1.3 Europe Digital Pathology Market Size by End-use 2019 -2031
-
3.1.3.1 Europe Pharma & Biotech Market Size
-
3.1.3.2 Europe Academia Market Size
-
3.1.3.3 Europe Hospitals Market Size
-
-
3.1.4 Europe Digital Pathology Market Size by Product 2019 -2031
-
3.1.4.1 Europe Scanner Market Size
-
3.1.4.2 Europe Software Market Size
-
3.1.4.3 Europe Storage System Market Size
-
-
Chapter 4 Asia Pacific Market Analysis
-
4.1 Asia Pacific Digital Pathology Market Size 2019 - 2031
-
4.1.1 Asia Pacific Digital Pathology Market Size By Country 2019 - 2031
-
4.1.2 Asia Pacific Digital Pathology Market Size by Type 2019 -2031
-
4.1.2.1 Asia Pacific Human Market Size
-
4.1.2.2 Asia Pacific Veterinary Market Size
-
-
4.1.3 Asia Pacific Digital Pathology Market Size by End-use 2019 -2031
-
4.1.3.1 Asia Pacific Pharma & Biotech Market Size
-
4.1.3.2 Asia Pacific Academia Market Size
-
4.1.3.3 Asia Pacific Hospitals Market Size
-
-
4.1.4 Asia Pacific Digital Pathology Market Size by Product 2019 -2031
-
4.1.4.1 Asia Pacific Scanner Market Size
-
4.1.4.2 Asia Pacific Software Market Size
-
4.1.4.3 Asia Pacific Storage System Market Size
-
-
Chapter 5 South America Market Analysis
-
5.1 South America Digital Pathology Market Size 2019 - 2031
-
5.1.1 South America Digital Pathology Market Size By Country 2019 - 2031
-
5.1.2 South America Digital Pathology Market Size by Type 2019 -2031
-
5.1.2.1 South America Human Market Size
-
5.1.2.2 South America Veterinary Market Size
-
-
5.1.3 South America Digital Pathology Market Size by End-use 2019 -2031
-
5.1.3.1 South America Pharma & Biotech Market Size
-
5.1.3.2 South America Academia Market Size
-
5.1.3.3 South America Hospitals Market Size
-
-
5.1.4 South America Digital Pathology Market Size by Product 2019 -2031
-
5.1.4.1 South America Scanner Market Size
-
5.1.4.2 South America Software Market Size
-
5.1.4.3 South America Storage System Market Size
-
-
Chapter 6 Middle East and Africa Market Analysis
-
6.1 Middle East and Africa Digital Pathology Market Size 2019 - 2031
-
6.1.1 Middle East and Africa Digital Pathology Market Size By Country 2019 - 2031
-
6.1.2 Middle East and Africa Digital Pathology Market Size by Type 2019 -2031
-
6.1.2.1 Middle East and Africa Human Market Size
-
6.1.2.2 Middle East and Africa Veterinary Market Size
-
-
6.1.3 Middle East and Africa Digital Pathology Market Size by End-use 2019 -2031
-
6.1.3.1 Middle East and Africa Pharma & Biotech Market Size
-
6.1.3.2 Middle East and Africa Academia Market Size
-
6.1.3.3 Middle East and Africa Hospitals Market Size
-
-
6.1.4 Middle East and Africa Digital Pathology Market Size by Product 2019 -2031
-
6.1.4.1 Middle East and Africa Scanner Market Size
-
6.1.4.2 Middle East and Africa Software Market Size
-
6.1.4.3 Middle East and Africa Storage System Market Size
-
-
Only Available with Corporate User License
Chapter 7 Top 10 Countries Analysis (Only Available with Corporate User License)
-
7.1 Country 1 Market Analysis
-
7.1.1 Country 1Digital Pathology Market Size by Type 2019 -2031
-
7.1.2 Country 1Digital Pathology Market Size by End-use 2019 -2031
-
7.1.3 Country 1Digital Pathology Market Size by Product 2019 -2031
-
-
7.2 Country 2 Market Analysis
-
7.2.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.3 Country 3 Market Analysis
-
7.3.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.4 Country 4 Market Analysis
-
7.4.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.5 Country 5 Market Analysis
-
7.5.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.6 Country 6 Market Analysis
-
7.6.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.7 Country 7 Market Analysis
-
7.7.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.8 Country 8 Market Analysis
-
7.8.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.9 Country 9 Market Analysis
-
7.9.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.10 Country 10 Market Analysis
-
7.10.1 Segmentation Analysis will be provided as shown for Country 1
-
Competitor's Market Share and Revenue (Subject to Data Availability for Private Players)
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
-
8.1 Top Competitors Analysis
-
8.1.1 Top Players Ranking 2022
-
8.1.2 Global Digital Pathology Market Revenue and Share by Manufacturers (2019-2023)
(Subject to Data Availability (Private Players))
-
8.1.3 Industry Mergers and Acquisition Analysis
-
8.1.4 New Product Launch Analysis
-
-
8.2 Company Profile (Data Subject to Availability)
-
8.2.1 Danaher Corporation
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.1.2 Business Overview
-
8.2.1.3 Financials (Subject to data availability)
-
8.2.1.4 Product Types Specification
-
8.2.1.5 Business Strategy
-
8.2.1.6 S.W.O.TAnalysis
-
-
8.2.2 Digipath
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.2.2 Business Overview
-
8.2.2.3 Financials (Subject to data availability)
-
8.2.2.4 Product Types Specification
-
8.2.2.5 Business Strategy
-
8.2.2.6 S.W.O.TAnalysis
-
-
8.2.3 Glencoe Software
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.3.2 Business Overview
-
8.2.3.3 Financials (Subject to data availability)
-
8.2.3.4 Product Types Specification
-
8.2.3.5 Business Strategy
-
8.2.3.6 S.W.O.TAnalysis
-
-
8.2.4 Hamamatsu Photonics
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.4.2 Business Overview
-
8.2.4.3 Financials (Subject to data availability)
-
8.2.4.4 Product Types Specification
-
8.2.4.5 Business Strategy
-
8.2.4.6 S.W.O.TAnalysis
-
-
8.2.5 Indica Labs
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.5.2 Business Overview
-
8.2.5.3 Financials (Subject to data availability)
-
8.2.5.4 Product Types Specification
-
8.2.5.5 Business Strategy
-
8.2.5.6 S.W.O.TAnalysis
-
-
8.2.6 Koninklijke Philips
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.6.2 Business Overview
-
8.2.6.3 Financials (Subject to data availability)
-
8.2.6.4 Product Types Specification
-
8.2.6.5 Business Strategy
-
8.2.6.6 S.W.O.TAnalysis
-
-
8.2.7 Nikon Corporation
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.7.2 Business Overview
-
8.2.7.3 Financials (Subject to data availability)
-
8.2.7.4 Product Types Specification
-
8.2.7.5 Business Strategy
-
8.2.7.6 S.W.O.TAnalysis
-
-
8.2.8 PerkinElmer
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.8.2 Business Overview
-
8.2.8.3 Financials (Subject to data availability)
-
8.2.8.4 Product Types Specification
-
8.2.8.5 Business Strategy
-
8.2.8.6 S.W.O.TAnalysis
-
-
8.2.9 Pixcelldata
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.9.2 Business Overview
-
8.2.9.3 Financials (Subject to data availability)
-
8.2.9.4 Product Types Specification
-
8.2.9.5 Business Strategy
-
8.2.9.6 S.W.O.TAnalysis
-
-
8.2.10 Visiopharm
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.10.2 Business Overview
-
8.2.10.3 Financials (Subject to data availability)
-
8.2.10.4 Product Types Specification
-
8.2.10.5 Business Strategy
-
8.2.10.6 S.W.O.TAnalysis
-
-
8.2.11 Leica Biosystems
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.11.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.11.2 Business Overview
-
8.2.11.3 Financials (Subject to data availability)
-
8.2.11.4 Product Types Specification
-
8.2.11.5 Business Strategy
-
8.2.11.6 S.W.O.TAnalysis
-
-
8.2.12 Ventana Medical Systems
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.12.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.12.2 Business Overview
-
8.2.12.3 Financials (Subject to data availability)
-
8.2.12.4 Product Types Specification
-
8.2.12.5 Business Strategy
-
8.2.12.6 S.W.O.TAnalysis
-
-
8.2.13 3DHISTECH
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.13.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.13.2 Business Overview
-
8.2.13.3 Financials (Subject to data availability)
-
8.2.13.4 Product Types Specification
-
8.2.13.5 Business Strategy
-
8.2.13.6 S.W.O.TAnalysis
-
-
8.2.14 HCL Technologies
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.14.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.14.2 Business Overview
-
8.2.14.3 Financials (Subject to data availability)
-
8.2.14.4 Product Types Specification
-
8.2.14.5 Business Strategy
-
8.2.14.6 S.W.O.TAnalysis
-
-
8.2.15 Pathology Devices
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.15.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.15.2 Business Overview
-
8.2.15.3 Financials (Subject to data availability)
-
8.2.15.4 Product Types Specification
-
8.2.15.5 Business Strategy
-
8.2.15.6 S.W.O.TAnalysis
-
-
8.2.16 Biogeniux
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.16.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.16.2 Business Overview
-
8.2.16.3 Financials (Subject to data availability)
-
8.2.16.4 Product Types Specification
-
8.2.16.5 Business Strategy
-
8.2.16.6 S.W.O.TAnalysis
-
-
8.2.17 OptraSCAN
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.17.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.17.2 Business Overview
-
8.2.17.3 Financials (Subject to data availability)
-
8.2.17.4 Product Types Specification
-
8.2.17.5 Business Strategy
-
8.2.17.6 S.W.O.TAnalysis
-
-
8.2.18 Pathcore
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.18.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.18.2 Business Overview
-
8.2.18.3 Financials (Subject to data availability)
-
8.2.18.4 Product Types Specification
-
8.2.18.5 Business Strategy
-
8.2.18.6 S.W.O.TAnalysis
-
-
8.2.19 Sectrae
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.19.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.19.2 Business Overview
-
8.2.19.3 Financials (Subject to data availability)
-
8.2.19.4 Product Types Specification
-
8.2.19.5 Business Strategy
-
8.2.19.6 S.W.O.TAnalysis
-
-
Chapter 9 Qualitative Analysis (Subject to Data Availability)
-
9.1 Market Drivers
-
9.2 Market Trends
-
9.3 Market Restraints
-
9.4 Market Opportunity
-
9.5 Product Life Cycle (Subject to Data Availability)
-
9.6 Industrial Chain Analysis (Subject to Data Availability)
-
9.6.1 Industry Chain Analysis
-
9.6.2 Manufacturing Cost Analysis
-
9.6.3 Consumer Preference Analysis
-
9.6.4 Supply Side Analysis
-
9.6.4.1 Raw Material Analysis
-
9.6.4.2 Raw Material Procurement Analysis
-
9.6.4.3 Raw Material Price Trend Analysis
-
-
-
9.7 Market Attractiveness Analysis
-
9.8 PESTEL Analysis
-
9.9 Porter’s Five Forces Analysis
-
9.10 Patent Analysis (Subject to Data Availability)
-
9.11 ESG Analysis
-
9.12 Technological Road Map
Segmentation Type Analysis 2019 -2031, will provide market size split by Type. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Type Analysis 2019 -2031
-
10.1 Human
-
10.1.1 Global Digital Pathology Revenue Market Size and Share by Human 2019 -2031
-
-
10.2 Veterinary
-
10.2.1 Global Digital Pathology Revenue Market Size and Share by Veterinary 2019 -2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by End-use Analysis 2019 -2031
-
11.1 Pharma & Biotech
-
11.1.1 Global Digital Pathology Revenue Market Size and Share by Pharma & Biotech 2019 - 2031
-
-
11.2 Academia
-
11.2.1 Global Digital Pathology Revenue Market Size and Share by Academia 2019 - 2031
-
-
11.3 Hospitals
-
11.3.1 Global Digital Pathology Revenue Market Size and Share by Hospitals 2019 - 2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Product Analysis 2019 -2031
-
12.1 Scanner
-
12.1.1 Global Digital Pathology Revenue Market Size and Share by Scanner 2019 -2031
-
-
12.2 Software
-
12.2.1 Global Digital Pathology Revenue Market Size and Share by Software 2019 -2031
-
-
12.3 Storage System
-
12.3.1 Global Digital Pathology Revenue Market Size and Share by Storage System 2019 -2031
-
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Digital Pathology market
Chapter 13 Research Findings
-
13.1 Key Takeaways
-
13.2 Analyst Point of View
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
-
13.3 Assumptions and Acronyms
Sample Format of Deliverables
The Tables, Graphs/Charts are only for representative purposes and do not depict actual statistics. Purchase full Report access to actual data.
Qualitative Analysis
Research Methodology Implemented by Anushka Gore and Team
- 1.1 Digital Pathology Market Report 2024 Research Methodology
- 1.2 Systematic Research Approach
- 1.2.1 Primary Research for Digital Pathology Market
- 1.2.1.1 Key Data from Primary
- 1.2.1.2 Primary Interviews with Experts
- 1.2.1.3 Key Industry Insights
- 1.2.1.4 Questionnaire for Digital Pathology Market
- 1.2.1.5 Breakdown of Primaries
- 1.2.2 Secondary Research for Digital Pathology Market
- 1.2.2.1 Key Data from Secondary
- 1.2.2.2 Paid Sources
- 1.2.2.3 Public Sources
- 1.3 Market Size Estimation for Digital Pathology Market
- 1.3.1 Top-Down Approach
- 1.3.1.1 Analyzing Market Size by Top-Down Approach (Supply Side)
- 1.3.2 Bottom-UP Approach
- 1.3.2.1 Analyzing Market Size by Bottom-Up Approach (Demand Side)
- 1.3.1 Top-Down Approach
- 1.4 Market Breakdown and Data Triangulation
- 1.5 Research Assumptions for Digital Pathology Market
Key Questions Answered By Digital Pathology Market Report 2024
| Why Human have a significant impact on Digital Pathology market? |
| What are the key factors affecting the Human and Veterinary of Digital Pathology Market? |
| What is the CAGR/Growth Rate of Pharma & Biotech during the forecast period? |
| By type, which segment accounted for largest share of the global Digital Pathology Market? |
| Which region is expected to dominate the global Digital Pathology Market within the forecast period? |
| Segmentation Level Customization |
|
| Global level Data Customization |
|
| Region level Data Customization |
|
| Country level Data Customization |
|
| Company Level |
|
| Additional Data Analysis |
|
| Additional Qualitative Data |
|
| Additional Quantitative Data |
|
| Service Level Customization |
|
Report Format Alteration |
|
